| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Topspin Fund L.P. last filed a Form 4 in November 2020, as 10% Owner at ORIC. The filings on record cover 2 companies.
At the last filing, the largest reported position was 1,100,446 shares of ORIC. The ORIC filings lean toward selling, a net 2,268,750 shares.
Topspin Fund L.P. has 4 Form 4 filings on record from November 2019 to November 2020, across 2 companies: 10% Owner at Oric Pharmaceuticals (ORIC), 2020; 10% Owner at RAPT Therapeutics (RAPT), 2019–2020.
The 7 reported transactions were 4 conversions, 2 open-market sales and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $5.0M and no sales.
The only open-market purchase was 415,000 shares of RAPT at an average $12.00 on November 4, 2019, about $5.0M.
Shares as reported in the last Form 4 for each company; the most recent is from November 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.